Ironwood Pharmaceuticals Investor Relations Material
Latest events
Q4 2024
Ironwood Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Ironwood Pharmaceuticals Inc
Access all reports
Ironwood Pharmaceuticals Inc is a gastrointestinal-focused healthcare company that develops and markets therapies for chronic digestive diseases. The company’s product portfolio includes treatments for irritable bowel syndrome and other gastrointestinal conditions. The company is headquartered in Boston, Massachusetts, and its shares are listed on the NASDAQ.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
IRWD
Country
🇺🇸 United States